Ethyl 5-(4-chlorophenyl)-2-methyl-1-phenylpyrrole-3-carboxylate

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯
• 英文名称: Ethyl 5-(4-chlorophenyl)-2-methyl-1-phenylpyrrole-3-carboxylate
• 化学式: C₂₀H₁₈ClNO₂
• 分子量: 339.8
• InChiKey: RYNBQQWODYCGRR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  24
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  31.2
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  Ethyl 5-(4-chlorophenyl)-2-methyl-1-phenylpyrrole-3-carboxylate 、 sodium hydroxide 以90%的产率得到
  参考文献：
  名称：

  PORRETTA, G. C.;CERRETO, F.;FIORAVANTI, R.;BIAVA, M.;SCALZO, M.;SIMONETTI+, FARMACO. ED. SCI., 44,(1989) N, C. 65-76

  摘要：

  DOI：
• 作为产物：
  描述：

  2-乙酰基-4-(4-氯苯基)-4-氧代丁酸乙酯 、 苯胺 生成 Ethyl 5-(4-chlorophenyl)-2-methyl-1-phenylpyrrole-3-carboxylate
  参考文献：
  名称：

  Pyrrolo- and Thiazolo-pyridine compounds, and methods of use thereof

  摘要：

  本发明涉及能够调节缺氧诱导因子（HIF）稳定性和/或活性的新化合物。

  公开号：

  US07696223B2

文献信息

• PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF
  申请人：DENG Shaojiang

  公开号：US20080004309A1

  公开（公告）日：2008-01-03

  The present invention relates to novel compounds capable of modulating the stability and/or activity of hypoxia inducible factor (HIF).

  这项发明涉及一种能够调节缺氧诱导因子（HIF）稳定性和/或活性的新化合物。
• THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS
  申请人：Fibrogen, Inc.

  公开号：EP3124489A1

  公开（公告）日：2017-02-01

  The present invention relates to novel compounds of formula I wherein: q is 0 or 1; • A is -S- and B is =N-; or • A is =N- and B is -S-; one of -A≃C(R6)- or -B≃C(R6)- is a double bond and the other is a single bond; R1 is selected from the group consisting of hydroxyl, alkoxy, substituted alkoxy, acyloxy, cycloalkoxy, substituted cycloalkoxy, aryloxy, substituted aryloxy, heteroaryloxy, substituted heteroaryloxy, heterocyclyloxy, substituted heterocyclyloxy, mercapto, thioether, sustituted alkylthio, arylsulfanyl, heteroarylsulfanyl, amino, substituted amino, acylamino, and aminoacyl; R2is selected from the group consisting of hydrogen, deuterium, and methyl; R3 is selected from the group consisting of hydrogen, deuterium, alkyl, and substituted alkyl; R4 is selected from the group consisting of hydrogen, alkyl, and substituted alkyl; and R5 and R6 are as defined in claim 1; capable of modulating the stability and/or activity of hypoxia inducible factor (HIF).

  本发明涉及式 I 的新型化合物 其中 q 是 0 或 1； - A 是-S-，B 是＝N-；或 - A 是 =N-，B 是 -S-； -A≃C(R6)-或-B≃C(R6)-中的一个是双键，另一个是单键； R1 选自由羟基、烷氧基、取代的烷氧基、酰氧基、环烷氧基、取代的环烷氧基、芳氧基、取代的芳氧基、杂芳氧基、取代的杂芳氧基、杂环氧基、取代的杂环氧基、巯基、硫醚、取代的烷硫基、芳硫基、杂芳硫基、氨基、取代的氨基、酰氨基和氨基酰基组成的组； R2 选自氢、氘和甲基组成的组； R3 选自氢、氘、烷基和取代烷基组成的组； R4 选自由氢、烷基和取代烷基组成的组；以及 R5 和 R6 如权利要求 1 所定义； 能调节缺氧诱导因子（HIF）的稳定性和/或活性。
• EP2016078B1
  申请人：——

  公开号：EP2016078B1

  公开（公告）日：2016-06-15
• PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS
  申请人：FIBROGEN, INC.

  公开号：EP2016078A2

  公开（公告）日：2009-01-21
• NOVEL METHODS, COMPOUNDS, AND COMPOSITIONS FOR ANESTHESIA
  申请人：THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY

  公开号：US20180022698A1

  公开（公告）日：2018-01-25

  Methods of treatment useful in the inducement or maintenance of anesthesia in a subject are provided. The methods comprise administering to a subject in need of anesthesia a compound disclosed herein. Also provided are novel compounds having anesthetic effects, pharmaceutical compositions comprising the compounds, and packaged pharmaceuticals. Computer modeling of the compounds demonstrates favorable interactions with the GABA receptor type A. In addition, the compounds display reversible anesthetic effects in an animal model, with dose-response curves similar to those of known general anesthetics. GABA receptor-mediated effects are also demonstrated in a hippocampal brain slice preparation.